5 Doctor-Supervised GLP-1 Programs That Are Actually Worth the Money

You did the research. You talked yourself into trying a GLP-1. Now you’re staring at a browser full of telehealth brands, all promising “personalized care” at wildly different price points, and you genuinely cannot tell which ones have a real physician in the loop and which ones are just a questionnaire with a rubber-stamp signature at the end.

That’s the situation most buyers are in. Here’s a short, opinionated list of the programs worth a serious look, and why.

1. FormBlends

Most weight-loss telehealth brands sell exactly one thing: a GLP-1 injectable and a monthly membership fee stacked on top of it. FormBlends does something structurally different. The intake is online, a licensed physician reviews and approves the prescription, and the medication ships from a licensed 503A compounding pharmacy that operates under cGMP standards and FDA inspection requirements. Available in 47 states with cold-chain shipping included.

What separates it at the quality level: every batch gets three independent laboratory checks before it ships. Identity is confirmed by mass spectrometry. Purity is measured by HPLC. A separate sterility check rounds out the process. The resulting numbers are published by product, not hidden behind a vague “third-party tested” claim. Semaglutide comes in at 99.1% purity; tirzepatide at 99.3%. Those are specific, verifiable figures, not marketing language.

Pricing is posted before you create an account. No membership layer obscuring what you’re actually paying for medication. Compounded semaglutide is $299 a vial; tirzepatide sits at $349. Those prices are for the medication itself, not a bundle that buries the real number two screens later.

The wider catalog matters too. This is one of the only physician-overseen platforms where someone managing their weight can also explore peptide therapies like BPC-157 ($54 per vial) or growth hormone secretagogues, under the same clinical roof, not from a gray-market research vendor with zero prescription oversight. For buyers who want GLP-1 plus muscle-preservation or recovery support, that combination is genuinely rare. Human evidence on non-GLP-1 peptides is still largely preclinical; the honest answer is that they’re worth tracking, not treating as proven.

One caveat: compounded medications are not FDA-approved finished drugs. That’s true across every compounding pharmacy, not just this one.

2. Mochi Health

Mochi‘s headline stat is the one that actually matters for long-term outcomes: the clinicians doing the prescribing are board-certified in obesity medicine, not just general practice physicians filling GLP-1 scripts on the side. That distinction changes the conversation you have with your provider.

Compounded semaglutide runs roughly $99 a month; compounded tirzepatide around $199. Three- and twelve-month commitments bring those numbers down further. For patients who also want a path to branded medication with insurance coverage, Mochi handles that too.

Clinical monitoring here is more hands-on than what you’ll find at some faster, lighter-touch platforms. That’s a real trade-off, not a marketing point.

3. Hims and Hers

After a settlement with Novo Nordisk took effect in March 2026, Hims and Hers moved new patients off compounded semaglutide onto branded medications. That shift made headlines, but for a lot of patients it’s actually a better outcome. Branded Wegovy at $299 a month (injectable) or $249 for the oral formulation, and Zepbound at $399, are prices that, combined with commercial insurance and a manufacturer savings card, can drop into the $0 to $25 per month range for eligible patients.

The app is polished. Onboarding is genuinely fast. If you have good insurance and want a clean, well-built experience with FDA-approved drugs, this is a reasonable first stop.

4. Ro Body

Ro’s model is built for patients who need help fighting through insurance prior-authorization, which is the part of getting branded GLP-1s that most people give up on. The platform has a dedicated team for that process, which is worth real money if your insurer keeps throwing up walls.

Membership starts around $39 for the first month, then runs as low as $74 a month on an annual prepay or $149 month-to-month. Medication is billed separately. For someone who wants a recognizable brand, insurance support, and a polished digital experience, Ro earns its position.

5. MEDVi

MEDVi does something a lot of platforms skip: it doesn’t require a membership fee on top of the medication cost. First-month compounded GLP-1 pricing runs around $179, no contract, physician review included, and 24/7 support is part of the package rather than an upsell.

It’s a lean setup. That suits buyers who want straightforward access without being locked into a 12-month commitment before they know whether the medication works for them.

One Thing Worth Watching Right Now

Early 2026 was messy for compounded GLP-1s. The FDA sent warning letters to more than 30 companies over marketing claims, and the Novo Nordisk settlement pushed a wave of platforms toward branded medications. Some brands adapted well; others simply pulled their compounding programs with no real alternative. The market is not the same as it was 18 months ago, and whatever you read in a review from late 2024 may describe a program that no longer exists in the same form.

Verify current availability for your state before you hand over a credit card.

Every program on this list reflects publicly available pricing and program structure as of May 2026. None of this is a substitute for a conversation with the physician who actually knows your bloodwork, your history, and your other medications. Do your own homework, and loop in whoever manages your care before starting any injectable therapy.